Head of U.S. Insights to Impact
Brandon Drew is Head of U.S. Insights to Impact at UCB, leading a team across finance, strategy, and operations across UCB’s U.S. business to leverage insights and align our resources to have the greatest impact for patients.
Brandon most recently served as global Head of the Bone Health Mission focused on UCB’s work to deliver solutions for people living with post-fracture osteoporosis. In 2017, he created and led the Fracture Demands Action mission focused on efforts to close the treatment gap for osteoporosis patients after fracture. Prior to that, he led UCB’s alliance with Amgen to develop the commercial collaboration model for the launch of Evenity. Today, UCB’s teams have impacted more than 300 hospital systems treating more than 150,000 fracture patients (2021 data).
Brandon joined UCB in 2007, serving in commercial operations, global business development, and leading several teams in U.S. market access and pricing before joining the Bone team. Prior to joining UCB, Brandon was a management consultant with ZS Associates in Chicago, leading projects ranging from market research and field force analytics to incentive compensation and marketing strategy. He has held previous roles in marketing, business development, consulting and engineering in the healthcare, technology and energy industries.
He holds a bachelor of chemical engineering degree from the Georgia Institute of Technology and a master of business administration degree from Northwestern University’s Kellogg School of Management.